Skip to main navigation Skip to search Skip to main content

Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalClinical Rheumatology
StatePublished - 2021.05.1

Cite this